Andere talen 180 Life Sciences Corp.

Aandelen

KBLM

US68236V3024

Vertraagde tijd Nasdaq Andere beurzen 19:37:06 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,1 ^USD	+7,14%		+10,52%	-48,23%

25/03	180 Life Sciences Corp. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
11/03	180 Life Sciences Corp. Kondigt wijzigingen in de Raad van Bestuur aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
180 Life Sciences : Corporate Presentation	15/03
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement	14/03
180 Life Sciences Corp. Announces Board Changes	11/03
180 Life Sciences Corp. Appoints Blair Jordan as A Member of the Board of Directors	29/02
180 Life Sciences to Conduct 1-For-19 Reverse Stock Split	26/02
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan	26/02
180 Life Sciences Corp. announced a financing transaction	21/02
180 Life Sciences Corp. Announces Board Resignations	21/12
180 Life Sciences Corp. Announces Resignation of Donald A. Mcgovern, as Member of the Board of Directors	20/12
180 Life Sciences Hires Financial Adviser to Help Explore Strategic Alternatives	04/12
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	04/12
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	04/12
180 Life Sciences : Material Agreement - Form 8-K	29/11
180 Life Sciences Announces Review of Strategic Alternatives	28/11
180 Life Sciences Announces Review of Strategic Alternatives	28/11
Certain Warrants of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13/11
Certain Stock Options of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13/11
Certain Common Stock of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023.	13/11
180 Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen 180 Life Sciences Corp.

Aandelen

KBLM

US68236V3024

Andere talen

Filters